Roflumilast is a molecule used for the treatment of chronic obstructive pulmonary disease (COPD), plaque psoriasis, seborrheic dermatitis, and atopic dermatitis.
It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4), exhibiting anti-inflammatory effects.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | DAXAS, Daliresp |
|---|---|
| IUPAC Name | 3-(cyclopropylmethoxy)-N-(3, 5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide |
| CAS | 162401-32-3 |
| Molecular Weight | 403.2 |
| Molecular Formula | C17H14Cl2F2N2O3 |
| SMILES | C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F |